科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/01/12 | 3,501 | 3,514 | 3,471 | 3,480 | -15 | -0.4% | 91,700 |
| 2024/01/11 | 3,510 | 3,513 | 3,476 | 3,495 | +2 | +0.1% | 112,900 |
| 2024/01/10 | 3,456 | 3,508 | 3,445 | 3,493 | +44 | +1.3% | 149,400 |
| 2024/01/09 | 3,394 | 3,452 | 3,394 | 3,449 | +55 | +1.6% | 180,400 |
| 2024/01/05 | 3,406 | 3,409 | 3,378 | 3,394 | -6 | -0.2% | 122,700 |
| 2024/01/04 | 3,350 | 3,405 | 3,326 | 3,400 | +45 | +1.3% | 129,500 |
| 2023/12/29 | 3,369 | 3,375 | 3,330 | 3,355 | +23 | +0.7% | 125,300 |
| 2023/12/28 | 3,299 | 3,334 | 3,291 | 3,332 | +33 | +1% | 66,900 |
| 2023/12/27 | 3,261 | 3,299 | 3,261 | 3,299 | +37 | +1.1% | 102,900 |
| 2023/12/26 | 3,252 | 3,279 | 3,252 | 3,262 | +12 | +0.4% | 76,000 |
| 2023/12/25 | 3,271 | 3,283 | 3,250 | 3,250 | -8 | -0.2% | 57,300 |
| 2023/12/22 | 3,218 | 3,258 | 3,218 | 3,258 | +47 | +1.5% | 101,000 |
| 2023/12/21 | 3,209 | 3,215 | 3,194 | 3,211 | -5 | -0.2% | 72,400 |
| 2023/12/20 | 3,208 | 3,224 | 3,196 | 3,216 | +24 | +0.8% | 136,800 |
| 2023/12/19 | 3,196 | 3,206 | 3,183 | 3,192 | +3 | +0.1% | 118,900 |
| 2023/12/18 | 3,172 | 3,193 | 3,161 | 3,189 | -2 | -0.1% | 121,800 |
| 2023/12/15 | 3,233 | 3,233 | 3,175 | 3,191 | -43 | -1.3% | 231,600 |
| 2023/12/14 | 3,262 | 3,270 | 3,222 | 3,234 | -19 | -0.6% | 90,100 |
| 2023/12/13 | 3,249 | 3,264 | 3,233 | 3,253 | -11 | -0.3% | 117,000 |
| 2023/12/12 | 3,293 | 3,293 | 3,259 | 3,264 | -9 | -0.3% | 104,800 |
| 2023/12/11 | 3,273 | 3,292 | 3,258 | 3,273 | ±0 | ±0% | 85,900 |
| 2023/12/08 | 3,314 | 3,319 | 3,267 | 3,273 | -35 | -1.1% | 116,800 |
| 2023/12/07 | 3,331 | 3,336 | 3,299 | 3,308 | -29 | -0.9% | 107,600 |
| 2023/12/06 | 3,324 | 3,344 | 3,315 | 3,337 | +7 | +0.2% | 104,900 |
| 2023/12/05 | 3,350 | 3,357 | 3,323 | 3,330 | -8 | -0.2% | 80,200 |
| 2023/12/04 | 3,369 | 3,369 | 3,327 | 3,338 | -53 | -1.6% | 105,100 |
| 2023/12/01 | 3,391 | 3,406 | 3,375 | 3,391 | +13 | +0.4% | 95,100 |
| 2023/11/30 | 3,337 | 3,378 | 3,335 | 3,378 | +35 | +1% | 145,300 |
| 2023/11/29 | 3,346 | 3,367 | 3,343 | 3,343 | -3 | -0.1% | 105,800 |
| 2023/11/28 | 3,326 | 3,347 | 3,323 | 3,346 | +20 | +0.6% | 98,900 |
| 2023/11/27 | 3,333 | 3,344 | 3,320 | 3,326 | ±0 | ±0% | 70,100 |
| 2023/11/24 | 3,301 | 3,326 | 3,289 | 3,326 | +27 | +0.8% | 79,600 |
| 2023/11/22 | 3,263 | 3,303 | 3,263 | 3,299 | +22 | +0.7% | 94,800 |
| 2023/11/21 | 3,230 | 3,289 | 3,223 | 3,277 | +52 | +1.6% | 178,500 |
| 2023/11/20 | 3,249 | 3,261 | 3,225 | 3,225 | -25 | -0.8% | 146,800 |
| 2023/11/17 | 3,210 | 3,250 | 3,190 | 3,250 | +49 | +1.5% | 154,900 |
| 2023/11/16 | 3,218 | 3,232 | 3,197 | 3,201 | -11 | -0.3% | 135,800 |
| 2023/11/15 | 3,212 | 3,229 | 3,188 | 3,212 | +11 | +0.3% | 144,400 |
| 2023/11/14 | 3,220 | 3,222 | 3,189 | 3,201 | -8 | -0.2% | 139,400 |
| 2023/11/13 | 3,263 | 3,265 | 3,208 | 3,209 | -46 | -1.4% | 138,800 |
| 2023/11/10 | 3,235 | 3,264 | 3,233 | 3,255 | +4 | +0.1% | 123,100 |
| 2023/11/09 | 3,305 | 3,324 | 3,218 | 3,251 | -82 | -2.5% | 299,300 |
| 2023/11/08 | 3,336 | 3,377 | 3,313 | 3,333 | +22 | +0.7% | 314,200 |
| 2023/11/07 | 3,338 | 3,352 | 3,311 | 3,311 | -2 | -0.1% | 107,200 |
| 2023/11/06 | 3,355 | 3,355 | 3,312 | 3,313 | -37 | -1.1% | 113,600 |
| 2023/11/02 | 3,350 | 3,352 | 3,333 | 3,350 | ±0 | ±0% | 78,200 |
| 2023/11/01 | 3,361 | 3,369 | 3,336 | 3,350 | +17 | +0.5% | 158,100 |
| 2023/10/31 | 3,289 | 3,340 | 3,289 | 3,333 | +51 | +1.6% | 109,300 |
| 2023/10/30 | 3,311 | 3,322 | 3,278 | 3,282 | -66 | -2% | 130,600 |
| 2023/10/27 | 3,329 | 3,349 | 3,308 | 3,348 | +30 | +0.9% | 62,600 |
351～
400
件表示中 / 3723件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 386,000円 | -6.4% | -71.8% | 4.92% | 43.11倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 378,000円 | +21.7% | +999.9% | 0.00% | 15.84倍 | 5.24倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 299,900円 | +7.9% | -3.3% | 2.67% | 8.34倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 203,900円 | +3.1% | -6.5% | 2.35% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
